Alto Neuroscience, Inc. (ANRO) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 26 transactions totaling $10.2M, demonstrating a bullish sentiment with $10.2M in net insider flow. The most recent transaction on Jan 2, 2026 involved a transaction of 3,806 shares valued at $45.0K.
No significant insider buying has been recorded for ANRO in the recent period.
No significant insider selling has been recorded for ANRO in the recent period.
Based on recent SEC filings, insider sentiment for ANRO is bullish with an Insider Alignment Score of 100/100 and a net flow of $10.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Alto Neuroscience, Inc. (ANRO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading ANRO stock, having executed 26 transactions in the past 90 days. The most active insider is Wave Global, Lp Alpha (Executive), who has made 3 transactions totaling $9.6M.
Get notified when executives and directors at ANRO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Sanchez Ramiro | Executive | Award | 3,806 | $11.82 | $45.0K | |
| Jan 2, 2026 | Manji Husseini | Executive | Award | 4,228 | $11.82 | $50.0K | |
| Jan 2, 2026 | Nixon Cox Christopher | Executive | Award | 7,189 | $11.82 | $85.0K | |
| Jan 2, 2026 | York Gwill | Executive | Award | 5,243 | $11.82 | $62.0K | |
| Jul 10, 2024 | Savitz Adam | Executive | Purchase | 2,931 | $13.22 | $38.7K | |
| Jul 9, 2024 | Savitz Adam | Executive | Purchase | 1,388 | $13.15 | $18.3K | |
| Jul 9, 2024 | Savitz Adam | Executive | Purchase | 10,681 | $12.53 | $133.8K | |
| Mar 28, 2024 | Conrad Smith Nicholas | Executive | Purchase | 4,550 | $16.56 | $75.3K | |
| Mar 28, 2024 | Conrad Smith Nicholas | Executive | Purchase | 1,600 | $15.80 | $25.3K | |
| Mar 1, 2024 | Etkin Amit | Executive | Award | 34,711 | $N/A | $0 | |
| Mar 1, 2024 | Conrad Smith Nicholas | Executive | Award | 19,153 | $N/A | $0 | |
| Feb 6, 2024 | Yu (jeff) Chen Po | Executive | Conversion | 39,259 | $N/A | $0 | |
| Feb 6, 2024 | Yu (jeff) Chen Po | Executive | Conversion | 8,450 | $N/A | $0 | |
| Feb 6, 2024 | Etkin Amit | Executive | Conversion | 11,777 | $N/A | $0 | |
| Feb 6, 2024 | Etkin Amit | Executive | Purchase | 3,125 | $16.00 | $50.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 9 | $10.2M | 97.7% |
Award(A) | 6 | $241.9K | 2.3% |
Conversion(C) | 11 | $0 | 0.0% |
Insiders at Alto Neuroscience, Inc. are accumulating shares at an accelerated pace. With 10 insiders making 26 transactions totaling $10.2M in purchases versus $0 in sales, the net buying activity of $10.2M signals strong executive confidence. Wave Global, Lp Alpha (Executive) leads the buying activity with $9.6M in transactions across all time.